Streetbeat News

Stock Prices

RGEN

Repligen has lowered its FY23 revenue guidance to $635M-$665M, down from the previous range of $720M-$760M and below the consensus of $721.07M. The company also revised its adjusted EPS forecast to $1.72-$1.80, compared to the previous guidance of $2.35-$2.42 and consensus of $2.29.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:02 am

AMD

QQQ

SBUX

SPY

TSLA

US stock futures fell on Wednesday due to a U.S. sovereign rating downgrade by Fitch, intensifying concerns about market overbought conditions. The downgrade was attributed to fiscal indiscipline and governance challenges. Amidst this, the market is absorbing a stream of earnings reports. Traders are also expressing unease over rising bond yields and await insights from a private payrolls survey. In premarket trading, the SPDR S&P 500 ETF Trust (NYSE:SPY) fell 0.43% and the Invesco QQQ ETF (NASDAQ:QQQ) slumped 0.70%. Several companies including Advanced Micro Devices, Inc. (NASDAQ:AMD), Starbucks Corp. (NASDAQ:SBUX), and Tesla, Inc. (NASDAQ:TSLA) saw movements in their stock prices following their quarterly results announcements.

Portfolio Pulse from Shanthi Rexaline

August 04, 2023 | 11:02 am

AVA

Avista Corporation has confirmed its 2023 consolidated EPS guidance of $2.27-$2.47. However, due to higher costs under ERM, the company expects to be in the lower end of these ranges. The consensus estimate was $2.32.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:02 am

ROAD

Construction Partners has revised its FY23 revenue forecast to $1.535B-$1.555B, down from the previous range of $1.530B-$1.580B. This is slightly below the estimated $1.57B.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:01 am

RGEN

Repligen (NASDAQ:RGEN) reported Q2 earnings of $0.53 per share, beating the analyst consensus estimate of $0.49 by 8.16%. However, this is a 41.76% decrease from the same period last year. The company's quarterly sales of $159.20 million missed the analyst consensus estimate of $167.15 million by 4.76%, marking a 23.33% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:01 am

CLH

Clean Harbors (NYSE:CLH) reported Q2 earnings of $2.13 per share, beating the analyst consensus estimate of $2.09 by 1.91%. However, this is a 12.7% decrease from the same period last year. The company's quarterly sales of $1.40 billion missed the analyst consensus estimate of $1.41 billion by 0.92%, but it's a 3.02% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:01 am

ROAD

Construction Partners (NASDAQ:ROAD) reported Q3 earnings of $0.41 per share, beating the analyst consensus estimate of $0.34 by 20.59%. This is a 78.26% increase from the same period last year. However, the company's quarterly sales of $421.89 million missed the analyst consensus estimate of $433.81 million by 2.75%, though it's a 10.95% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:00 am

ICPT

Intercept Pharmaceuticals has updated its FY23 net sales guidance for Ocaliva to $320-$340 million, up from $310-$340 million. The company also lowered its 2023 non-GAAP adjusted operating expense guidance to $350-$370 million, inclusive of restructuring costs. Intercept is on track to achieve a net reduction in annual non-GAAP adjusted operating expenses of approximately $140 million.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:00 am

CRTO

Criteo has projected a high single-digit to low double-digit growth in contribution ex-TAC at constant currency for FY23.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:59 am

AKRO

CROX

TBBK

Insider trades were noted in Akero Therapeutics, Crocs, and The Bancorp. Akero Therapeutics Director Walmsley Graham acquired 55,000 shares at an average price of $42.95, costing around $2.36 million. Crocs Director Thomas Smach acquired 1,435 shares at an average price of $104.53, costing around $150,001. The Bancorp Director Matthew Cohn bought 5,868 shares at an average price of $37.61, costing around $220,688.

Portfolio Pulse from Lisa Levin

August 04, 2023 | 10:58 am